Browsing Category
Lipids
From Lab Bench to Bedside: Advancing Malaria Treatments through Research, Patents, and Clinical…
Abstract
Purpose of Review
Conventional antimalarial therapies often encounter issues of drug resistance, low bioavailability, and systemic toxicity. However, recent advancements in nanotechnology have opened new avenues for revolutionizing malaria treatment through precise drug delivery…
Read More...
Read More...
Enhancing oral bioavailability of dasatinib via supersaturable SNEDDS: Investigation of…
Abstract
Dasatinib (DASA), a potent second-generation multitarget kinase inhibitor marketed as Sprycel® (Tablet), is limited by poor oral bioavailability (14–24 %) and dose-related gastrointestinal side effects. A supersaturable self-nanoemulsifying drug delivery system (su-SNEDDS) designed to…
Read More...
Read More...
HSPiP and quality by design aided optimized bioanalytical method development for amphotericin B…
Abstract
Amphotericin-b (AmB) is a broad-spectrum polyene macrolide antifungal and anti-Leishmaniosis. We addressed HSPiP and QbD (quality by design) oriented HPLC (high-performance liquid chromatography) method development and validation, followed by identifying critical attributes on retention…
Read More...
Read More...
Characteristics and Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
Abstract
Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have emerged as promising systems for delivering active ingredients. They are derived from physiological, biodegradable, and biocompatible lipids, offering benefits such as sustained release promotion and increased…
Read More...
Read More...
Lipid Nanoparticle Formulations for the Skin Delivery of Cannabidiol
Abstract
Background/Objectives: The aims of this work were to formulate cannabidiol in different lipid carriers for skin delivery after topical application and to study their stability, interaction with the skin, and antibacterial activity.
Methods: Solid lipid nanoparticles and nanostructured…
Read More...
Read More...
Patent on controlled release formulations of highly lipophilic physiologically active substances
The patent application US20240139215A1 focuses on the development of controlled release formulations for highly lipophilic physiologically active substances, such as cannabinoids. These substances tend to have high lipid solubility (log P of 4 or more), making them difficult to deliver in a…
Read More...
Read More...
Evaluation of the Potential of Novel Co-Processed Excipients to Enable Direct Compression and…
Abstract
Background/Objectives: Improving the production rates of modern tablet presses places ever greater demands on the performance of excipients. Although co-processing has emerged as a promising solution, there is still a lack of directly compressible excipients for modified-release…
Read More...
Read More...
Development of targeted lipid nanoparticles for the combined therapy of triple negative breast…
Abstract
In the study of triple-negative breast cancer (TNBC) therapeutic approaches, researchers have recently focused on exploiting P-glycoprotein (P-gp) and hypoxia-inducible factor (HIF) inhibitors to enhance the effectiveness of chemotherapeutic agents, which are often limited by poor…
Read More...
Read More...
Lipid extract from Black Soldier Fly larvae: A high value excipient for solid lipid nanoparticles…
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disorder with a complex pathogenesis involving epidermal barrier dysfunction and aberrant lipid composition, particularly ceramides and fatty acids (FA). Conventional management options, such as topical glucocorticoids (GC), often…
Read More...
Read More...
Leveraging machine learning to streamline the development of liposomal drug delivery systems
Abstract
Drug delivery systems efficiently and safely administer therapeutic agents to specific body sites. Liposomes, spherical vesicles made of phospholipid bilayers, have become a powerful tool in this field, especially with the rise of microfluidic manufacturing during the COVID-19 pandemic.…
Read More...
Read More...